[Translation] A randomized, double-blind, double-dummy, active drug/placebo-controlled, multicenter phase II clinical trial of Xinmaikang capsule in the treatment of coronary heart disease angina pectoris (qi stagnation and blood stasis and phlegm obstruction syndrome)
分别以安慰剂和阳性药为对照,初步评价心脉康胶囊治疗冠心病心绞痛(气滞血瘀兼痰阻证)的有效性和安全性
[Translation] Taking placebo and positive drug as control, respectively, to preliminarily evaluate the efficacy and safety of Xinmaikang Capsule in the treatment of coronary heart disease angina pectoris (qi stagnation and blood stasis and phlegm blocking syndrome)